BioBreak is a premium BioTech stock financial analysis tool. We use a proprietary algorithm to analyze the financials of BioTech companies and present the results in a simple and easy to understand format. We also provide a list of the top 10 BioTech stocks to watch. We are currently in beta and are working on adding more features.

Biobreak is the only BioTech stock analysis tool that provides a proprietary algorithm to analyze the financials of BioTech companies and present the results in a simple and easy to understand format.

We are currently in beta and are offering a free trial. After the trial period, the cost will $299/12 months

Yes, BioBreak takes account for catalyst events. We have a calendar that shows upcoming catalyst events for each company. We have graphs that show the price movement of each company before and after the catalyst event.

BioTech is a rapidly growing industry. The industry is expected to grow at a compound annual growth rate of 8.1% from 2019 to 2025. The industry is also expected to reach a market size of $1,189.9 billion by 2025. The industry is expected to grow due to the following factors: aging population, increasing prevalence of chronic diseases, increasing healthcare spending, and technological advancements.